Stock B6E SWEDISH ORPHAN BIOVITRUM AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Swedish Orphan Biovitrum AB Xetra

Equities

B6E

SE0000872095

Real-time Estimate Tradegate
Other stock markets
 15:59:58 2024-07-16 EDT 		5-day change 1st Jan Change
24.13 EUR 0.00% Intraday chart for Swedish Orphan Biovitrum AB 0.00% 0.00%
02:00pm Transcript : Swedish Orphan Biovitrum AB, Q2 2024 Earnings Call, Jul 16, 2024
08:00am Swedish Orphan Biovitrum AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Swedish Orphan Biovitrum AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
CI
Swedish Orphan Biovitrum AB Updates Earnings Guidance for the Year 2024
CI
Sweden's Sobi Begins Rolling Application for Gout Treatment in US
MT
Sobi Initiates Rolling Biologics License Application to FDA for SEL-212 for the Potential Treatment of Chronic Refractory Gout
CI
European Commission Grants Sobi® Marketing Authorisation for Altuvoct? for Treatment of Haemophilia A
CI
BerGenBio ASA Enter into A Clinical Trial Agreement with the Mays Cancer Center At the University of Texas Health Science Center At San Antonio and Swedish Orphan Biovitrum AB
CI
Sobi Finalizes Inaugural SEK3 Billion Bond Issue
MT
Sobi Secures Additional EU Indication for Rare Blood Disorder Therapy
MT
Sobi Wins EU Regulatory Panel's Positive Opinion for Hemophilia A Drug
MT
Sobi Receives Positive CHMP Opinion Recommending Approval of efanesoctocog alfa for Once-Weekly Treatment of Haemophilia A
CI
Sobi's SEK10 Billion Note Program Gets Regulatory Nod in Sweden
MT
Swedish Orphan Biovitrum AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Swedish Orphan Biovitrum AB Provides Earnings Guidance for 2024
CI
Sobi to Expand in South Korea via Rare Disease JV with Handok
MT
Orexo, Swedish Orphan Biovitrum to Further Explore AmorphOX Combination
MT
Orexo AB (Publ.) and Swedish Orphan Biovitrum AB (publ.) Agrees to Advance Feasibility Study with Amorphox
CI
Sobi's Growth Potential Remains 'Tremendous' Amid Conservative FY24 Outlook, RBC Says
MT
Swedish Orphan Biovitrum AB Provides Revenue Guidance for the Year 2024
CI
Swedish Orphan Biovitrum AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Swedish Orphan Biovitrum AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SOBI Stock
  4. B6E Stock
  5. News Swedish Orphan Biovitrum AB
  6. Highlights